PMC3364094_01
Course of the treatment of 6 cycles of AIET given intermittently with chemotherapy. The decrease in CA-125 values during the course of the treatment is also depicted. AH = AIET peripheral blood harvest; AT = AIET transfusions; CT = chemotherapy.
cro-0005-0114-g01.jpg
PMC3364094_01_cro-0005-0114-g01.jpg
F1
AIET transfusions given intravenously along with chemotherapy, CA-125 showed a considerable decrease to 4.7 U/ml as depicted in fig. 1. A CT scan taken in December 2010 showed a regression of the lesions in the spleen and perisplenic peritoneal deposits, stable hepatic lesions and resolution of perigastric peritoneal deposits (fig. 2).
CT scan of the patient taken after 3 cycles of immunotherapy and 6 cycles of chemotherapy in December 2010, showing static non-progressive lesions.
cro-0005-0114-g02.jpg
PMC3364094_01_cro-0005-0114-g02.jpg
F2
AIET transfusions given intravenously along with chemotherapy, CA-125 showed a considerable decrease to 4.7 U/ml as depicted in fig. 1. A CT scan taken in December 2010 showed a regression of the lesions in the spleen and perisplenic peritoneal deposits, stable hepatic lesions and resolution of perigastric peritoneal deposits (fig. 2).